溶栓剂的安全有效应用
摘要
人体发生血管内的急性血栓栓塞性疾病,致使供血器官组织发生相应的缺血性病理生理变化,以至于产生不可逆的重要脏器衰竭,如急性心肌梗死、脑梗死、肺栓塞等。及时的给予溶栓剂治疗,使闭塞血管再通,重要脏器迅速获得血液再灌注,扼制脏器衰竭的发生是很好的治疗方法。而且溶栓治疗需要的医疗保障环境相比于介入治疗,相对简易可行。
出处
《中国药物警戒》
2010年第5期288-289,共2页
Chinese Journal of Pharmacovigilance
参考文献2
-
1程显声,何建国,高明哲,陈光瑾,李树花,张中和,赵鸣武,周素敏,赵济文,成立珠,张珍祥,陈玉林,熊长明.急性肺血栓栓塞症溶栓及抗凝治疗多中心临床分析[J].中华内科杂志,2002,41(1):6-10. 被引量:123
-
2急性ST段抬高心肌梗死溶栓治疗中国专家共识(2009年版)[J].中华内科杂志,2009,48(10):885-890. 被引量:49
二级参考文献42
-
1杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:85
-
2DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med, 1980,303:897-902.
-
3Eagle KA, NaIIamothu BK, Mehta RH, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J, 2008 ,29 :609-617.
-
4Fassa AA, Urban P, Radovanovic D, et al. AMIS Plus Investigators. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland : six year results from a nationwide registry. Heart, 2005, 91:882-888.
-
5Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over I. 5 million patients with myocardial infarction in the US from 1990 through 1999.. the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coil Cardiol, 2000, 36: 2056-2063.
-
6Fox KA, Goodman SG, Anderson FA Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events ( GRACE ). Eur Heart J, 2003,24 : 1414 -1424.
-
7Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J, 2000, 21 : 1440-1449.
-
8Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro heart survey ACS). Eur Heart J, 2002, 23:1190-1201.
-
9Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet, 2005, 366: 1607- 1621.
-
10Llevadot J, Giugliano RP, Antman EM. Bolus fibrinolytic therapy in acute myocardial infarction. JAMA, 2001, 286: 422-429.
共引文献169
-
1吴周飞.尿激酶溶栓联合抗凝治疗肺栓塞临床效果观察[J].临床研究,2014,22(5):88-88.
-
2王远东,徐丽春,刘强.瑞替普酶与尿激酶静脉溶栓治疗急性ST段抬高型心肌梗死的临床比较分析[J].医学信息(医学与计算机应用),2014,0(10):161-161. 被引量:4
-
3余素琴,李小林.外科手术后并发静脉血栓形成17例临床分析[J].临床外科杂志,2002,10(z1):82-83.
-
4王金娥.肺栓塞18例临床分析[J].实用医技杂志,2008,15(25):3395-3396.
-
5时德.下肢深静脉血栓形成的危险因素和预防措施[J].中国血管外科杂志(电子版),2011,3(1):5-8. 被引量:17
-
6薛玉文,吴大玮,于钦凤,贾平东,杜以明.急性肺动脉栓塞症的溶栓治疗[J].山东大学学报(医学版),2004,42(4):416-418. 被引量:4
-
7龙振钊.脑卒中病人合并肺栓塞12例临床分析[J].中国神经精神疾病杂志,2004,30(5):398-398.
-
8刘艳霞.肺血栓栓塞的诊治现状[J].河北医学,2004,10(11):1052-1053.
-
9崔超巍.急性肺栓塞23例临床分析[J].临床医学,2004,24(12):19-20.
-
10闫俊瑾,时向民,王玉堂.腔静脉滤器的临床应用[J].医学临床研究,2004,21(9):1039-1041. 被引量:2
-
1陈其庆(编译).基因治疗遭遇死亡事件——FDA迅速叫停新药tgAAC94Ⅰ/Ⅱ期临床试验[J].中国卫生产业,2007(9):90-91.
-
2刘智勇,刘景艳,周平,陶尚成.重组链激酶与尿激酶治疗急性心肌梗死的疗效[J].湖南医学,2002,19(2):172-173.
-
3李晓惠,王彬尧,厉锦华,章隆泉,刘建平,何奔,张清.不同溶栓剂治疗急性心肌梗塞的比较[J].中国心血管杂志,1998,3(6):462-464.
-
4庞鹏,宋春雨.丙泊酚对缺血性脑损伤的抗凋亡作用[J].中国医药,2015,10(11):1710-1712. 被引量:4
-
5王环,梅晓蓉,周素素.血液净化救治利福平所致急性肾衰竭及多器官功能障碍综合征的护理[J].海峡药学,2010,22(7):153-154.
-
6杨帆.阿司匹林抵抗与心血管事件[J].新医学,2003,34(12):769-771. 被引量:4
-
7张新建,郭美华,杨丽杰,刘世萍,胡宝荣.174例苯乙双胍致乳酸性酸中毒文献分析[J].中国药物警戒,2013,10(2):103-106. 被引量:6
-
8暴晓平,刘云武.大剂量尿激酶溶栓治疗急性心肌梗死临床观察[J].黑龙江医学,2002,26(3):223-223.
-
9方健.生物靶向药物——癌症治疗的一缕朝阳[J].大众健康,2009(5):102-102.
-
10张友智,赵瑛.磺胺嘧啶铜的合成与质量控制[J].中国药房,2013,24(5):448-450.